This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n16http://linked.opendata.cz/resource/drugbank/drug/DB01885/identifier/chemspider/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01885/identifier/chebi/
n13http://bio2rdf.org/drugbank:
n15http://linked.opendata.cz/resource/drugbank/drug/DB01885/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB01885/identifier/kegg-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01885/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01885/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/resource/drugbank/drug/DB01885/identifier/drugbank/
n8http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n9http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01885
rdf:type
n8:Drug
n8:group
experimental
owl:sameAs
n6:DB01885 n13:DB01885
dcterms:title
D-Galctopyranosyl-1-On
adms:identifier
n4:DB01885 n7:151504 n10:46508286 n11:15945 n14:C02669 n15:149 n16:716
n8:IUPAC-Name
n9:271B4FFB-363D-11E5-9242-09173F13E4C5
n8:InChI
n9:271B5001-363D-11E5-9242-09173F13E4C5
n8:Molecular-Formula
n9:271B5000-363D-11E5-9242-09173F13E4C5
n8:Molecular-Weight
n9:271B4FFD-363D-11E5-9242-09173F13E4C5
n8:Monoisotopic-Weight
n9:271B4FFE-363D-11E5-9242-09173F13E4C5
n8:SMILES
n9:271B4FFF-363D-11E5-9242-09173F13E4C5
n8:Water-Solubility
n9:271B4FF9-363D-11E5-9242-09173F13E4C5
n8:logP
n9:271B4FFA-363D-11E5-9242-09173F13E4C5 n9:271B4FF7-363D-11E5-9242-09173F13E4C5
n8:logS
n9:271B4FF8-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Acceptor-Count
n9:271B5007-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Donor-Count
n9:271B5008-363D-11E5-9242-09173F13E4C5
n8:InChIKey
n9:271B5002-363D-11E5-9242-09173F13E4C5
n8:Polar-Surface-Area--PSA-
n9:271B5003-363D-11E5-9242-09173F13E4C5
n8:Polarizability
n9:271B5005-363D-11E5-9242-09173F13E4C5
n8:Refractivity
n9:271B5004-363D-11E5-9242-09173F13E4C5
n8:Rotatable-Bond-Count
n9:271B5006-363D-11E5-9242-09173F13E4C5
n8:casRegistryNumber
15892-28-1
n8:Bioavailability
n9:271B500D-363D-11E5-9242-09173F13E4C5
n8:Ghose-Filter
n9:271B500F-363D-11E5-9242-09173F13E4C5
n8:MDDR-Like-Rule
n9:271B5010-363D-11E5-9242-09173F13E4C5
n8:Number-of-Rings
n9:271B500C-363D-11E5-9242-09173F13E4C5
n8:Physiological-Charge
n9:271B500B-363D-11E5-9242-09173F13E4C5
n8:Rule-of-Five
n9:271B500E-363D-11E5-9242-09173F13E4C5
n8:Traditional-IUPAC-Name
n9:271B4FFC-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-acidic-
n9:271B5009-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-basic-
n9:271B500A-363D-11E5-9242-09173F13E4C5